Antibody Drug Conjugates Market Analysis

By -
Antibody Drug Conjugates Market by Drugs, Mechanism of Action and Application: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global antibody drug conjugates market accounted for $1,387 million in 2016, and is estimated to reach at $3,198 million by 2023, registering a CAGR of 12.9% from 2017 to 2023.
Download the sample Report @ http://bit.ly/2JGFQdD
Antibody drug conjugates are highly powerful biopharmaceutical medications prepared by integrating two principles i.e. a cell killing highly powerful active pharmaceutical ingredient (HPAPI) and explicit nature of monoclonal antibodies. They are highly effective anticancer drugs targeting only cancer infected cells thus, leaving healthy uninfected cell intact facilitating quick recovery of cancer patients.
Increase in prevalence of cancer and rise in demand for efficient and cost-effective cancer treatments drive the market. Moreover, extensive research on drug development and large number of pipeline drugs for ADCs present in different stages of approvals are expected to boost the market growth. Approval of pipelined drugs increase the number of available ADC products, cumulatively spurring market turnover of ADCs. However, strict regulation set by regulating authorities for approval of ADCs and complications associated with drug development impedes the growth of antibody drug conjugates market. Growth in adoption of ADCs over conventional cancer treatments and rapidly developing market in Asia-Pacific & LAMEA create opportunities for market players.
North America holds the highest market share in 2016 owing to high prevalence of cancer in the region and modern healthcare facilities for employment of novel therapeutic procedures. Moreover, adoption of experimental medicines and growth in awareness about antibody drug conjugates in the region is expected to boost the North American market. However, Asia-Pacific region is expected to grow at the highest CAGR during the forecast period considering, high reported prevalence of cancer constituting a large patient pool.

Key Findings of the Antibody Drug Conjugates Market:

  • The Kadcyla segment is projected to grow at the highest CAGR in 2016 during the analysis period.
  • Breast cancer segment generated the highest revenue in 2016 and is expected to continue its dominance in future.
  • North America dominated the market in 2016
  • China is expected to grow at the highest CAGR in 2016, in Asia-Pacific.
The key companies profiled in the report include F. Hoffman-La Roche Ltd., ImmunoGen, Inc., Bayer AG, Novartis AG, Immunomedics, Inc., Agensys, Inc., Takeda Pharmaceutical Company Limited, Seattle Genetics, Inc., Concortis Biotherapeutics, and NBE-Therapeutics.

Comments

Post a Comment

Popular posts from this blog

Doctors recommend for blood gas test if symptoms such as shortness of breath, difficulty in breathing, confusion

By -
Image
Blood gas analyzers  are used to measure different parameters such as pH, blood gas such as pCO2 and pO2, electrolytes, and metabolites from the whole blood sample.  Blood  is collected from the patient and introduced into the analyzer. The analyzer leads the blood into a measuring chamber, which has ion selective electrodes (IE), the electrodes that are sensitive only to the measurement of interest. This analysis of the blood sample helps to detect medical conditions such as kidney failure, heart failure, uncontrolled diabetes, hemorrhage, chemical poisoning, a drug overdose, shock, asthma, and chronic obstructive pulmonary disease (COPD). Doctors recommend for blood gas test if symptoms such as shortness of breath, difficulty in breathing, confusion, and nausea are witnessed. Global Blood Gas and Electrolyte Analyzers Market accounted for $1,427 million in 2016, and is anticipated to reach $2,104 million by 2023, registering a CAGR of 5.7%. In terms of volume, the global volume marke
Read more

Global Powered Surgical Instrument Market will generate $2,731 million by 2025

By -
According to a new report published by Allied Market Research, titled, "Powered Surgical Instrument Market by Product, Power Source, and Application: Global Opportunity Analysis and Industry Forecast, 2018 - 2025,"  the global powered surgical instrument market generated $1,943 million in 2017 and is projected to reach $2,731 million by 2025, growing at a CAGR of 4.2% from 2018 to 2025. The handpieces segment accounted for more than three-fifth of the total market share in 2017. Download the Sample Report @  https://www.alliedmarketresearch.com/request-sample/5091?utm_source=Blogger&utm_medium=Niranjan Powered surgical instruments are high-powered specially designed instruments that are used for performing specific or desired actions during a surgery. There are several high-powered surgical drill systems present in the market such as reamer systems, saw systems, stapler, shavers, and other handpieces, which are used during orthopedic, neuro, cardiovascular, cardioth
Read more

The global specialty enzymes market is expected to register a CAGR of 9.4% during 2021-2028

By -
Image
The global   specialty enzymes market   is expected to register a CAGR of 9.4% during 2015-2020. The pharmaceuticals application segment accounted for about half of the overall market share in 2014. The Asia Pacific market would exhibit the highest CAGR of 11.7% during the forecast period (2015-2020). Specialty enzymes are proteins that act as biocatalysts to accelerate chemical reaction and produce the desired results. Owing to low consumption and high degree of specificity, specialty enzymes are witnessing spurring demand in medical applications such as pharmaceutical, biotechnology research and diagnostics. The growing popularity of specialty enzymes in therapies for chronic diseases such as cancer, cardiovascular diseases, pain and inflammatory disorders among others is the vital force fuelling the market growth. In addition, growing awareness about enzyme-based therapeutics in the Asia Pacific and LAMEA region would further boost the market growth. However, safety concerns due to
Read more